Studies have demonstrated that macrophage-stimulating protein 1 (Mst1) mediates mitochondrial autophagy by regulating Parkin expression through the AMPK pathway, which further promotes NAFLD (74). Here, PRKN is linked to metabolic dysfunction-associated steatotic liver disease.